Evidence map›Paper›PMID 29993036›Full record

ArticleOncogene2018

PSTPIP2 connects DNA methylation to macrophage polarization in CCL4-induced mouse model of hepatic fibrosis.

Yang Yang, Xiao-Qin Wu, Wan-Xia Li, Hui-Min Huang, Hai-di Li, Xue-Yin Pan, Xiao-Feng Li, Cheng Huang, Xiao-Ming Meng, Lei Zhang and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  7. Acta pharmaceutica Sinica. B · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. IGF2-NR4A2 Signaling Regulates Macrophage Subtypes to Attenuate Liver Cirrhosis.Journal of clinical and translational hepatology · 2023
    Article
  16. Macrophages in immunoregulation and therapeutics.Signal transduction and targeted therapy · 2023
    Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Yang YangSchool of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, 230032, Hefei, China.
Xiao-Qin WuSchool of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, 230032, Hefei, China.
Wan-Xia LiSchool of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, 230032, Hefei, China.
Hui-Min HuangSchool of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, 230032, Hefei, China.
Hai-di LiSchool of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, 230032, Hefei, China.
Xue-Yin PanSchool of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, 230032, Hefei, China.
Xiao-Feng LiSchool of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, 230032, Hefei, China.
Cheng HuangSchool of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, 230032, Hefei, China.
Xiao-Ming MengSchool of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, 230032, Hefei, China.
Lei ZhangSchool of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, 230032, Hefei, China.
Xiong-Wen LvSchool of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, 230032, Hefei, China.
Hua WangSchool of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, 230032, Hefei, China.
Jun LiSchool of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, 230032, Hefei, China. lj@ahmu.edu.cn.
Ministry of Education of the People's Republic of China · CNAnhui Medical University · CN

Funding

National Natural Science Foundation of China (National Science Foundation of China) 81273526National Natural Science Foundation of China (National Science Foundation of China) 81473268National Natural Science Foundation of China (National Science Foundation of China) 81770609
6 · The paper itself

Abstract

Macrophages play a crucial role in the progression of hepatic fibrosis (HF). In macrophages, epigenetic mechanisms are increasingly being recognized as crucial controllers of their phenotype. However, the functions of macrophage DNA methylation in experimental models of hepatic fibrosis have not been fully addressed. Here, we analyzed isolated hepatic macrophages DNA methylation from CCL4-induced (4 weeks) mice using reduced representation bisulfite sequencing (RRBS). We identified and validated the methylation status of 26 gene promoter regions associated with CpG islands. We further investigated the function of PSTPIP2 in HF by hepatic-adeno-associated virus (AAV9)-PSTPIP2 overexpression. The molecular mechanisms underlying PSTPIPS2-regulated HF were further explored in mice and RAW264.7 cell line. RRBS results show hypermethylation of PSTPIP2 (chr18: 77,843,840-77,843,968) in the 5'-UTR region. PSTPIP2 expression was significantly decreased in isolated hepatic macrophages from CCL4-induced mice. PSTPIP2 hypermethylation is mediated by the methyltransferases DNMT3a and DNMT3b in LPS-induced RAW264.7 cell line. Further investigation indicated that specific overexpression of PSTPIP2 in C57BL/6 mice reduced the inflammatory response and ameliorated liver fibrosis. These data indicated that hypermethylation of PSTPIP2 caused a mixed induction of hepatic classical macrophage (M1) and alternative macrophage (M2) biomarkers in CCL4-induced HF mice. Furthermore, overexpression of PSTPIP2 inhibited the expression of M1 markers by suppressing STAT1 activity, and enhanced the expression of M2 markers by promoting STAT6 activity. In contrast, knockdown of PSTPIP2 promoted M1 polarization and suppressed M2 polarization in vitro. Adding PSTPIP2 expression alleviates liver fibrosis and hepatic inflammation in mice by regulating macrophage polarization.

Indexed as

5' Untranslated RegionsAdaptor Proteins, Signal TransducingAnimalsBiomarkersCarbon TetrachlorideCell LineCpG IslandsCytoskeletal ProteinsDisease Models, AnimalDNA MethylationEpigenesis, GeneticInflammationLiver CirrhosisMacrophagesMaleMice5' Untranslated RegionsAdaptor Proteins, Signal TransducingBiomarkersCarbon TetrachlorideCytoskeletal ProteinsPstpip2 protein, mouseSTAT1 Transcription Factor

Identifiers

PMID29993036
OpenAlexW2842475511

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.